Communiqués ENDRA Life Sciences Inc.

Actions

NDRA

US29273B3024

Marché Fermé - Nasdaq Autres places de cotation 19:30:00 03/07/2024			Varia. 5j.	Varia. 1 janv.
0,091 ^USD	+2,02 %		-8,45 %	-95,71 %

04/06	Mise à jour sectorielle : Les actions du secteur de la santé augmentent en fin d'après-midi	MT
04/06	Les plus fortes baisses de la mi-journée	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering	04/06	BU
ENDRA Provides Update Following In-person Meeting with FDA	20/05	BU
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update	14/05	BU
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024	07/05	BU
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents	02/05	BU
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	28/03	BU
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024	21/03	BU
ENDRA Life Sciences Installs First TAEUS System in the UK	27/02	BU
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences TAEUS System	22/02	AQ
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System	21/02	BU
ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe	15/02	AQ
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe	14/02	BU
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS System Technology	30/11	AQ
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology	29/11	BU
ENDRA Life Sciences to participate in the Benchmark Company's 12th Annual Discovery One-on-One Investor Conference	28/11	AQ
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference	27/11	BU
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update	14/11	BU
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023	09/11	AQ
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents	08/11	BU
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023	07/11	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ENDRA Life Sciences Inc.

Actions

NDRA

US29273B3024

Communiqués

Filtres